ACADIA Pharmaceuticals Inc. - Common Stock (NQ:ACAD)
All News about ACADIA Pharmaceuticals Inc. - Common Stock


Via Benzinga




















Acadia Trofinetide Phase III Clinical Top-Line Results Positive
November 16, 2022
Via AB Newswire

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
November 08, 2022
Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
November 04, 2022
Via Benzinga

Acadia Pharmaceuticals Reports Third Quarter 2022 Financial Results
November 02, 2022
Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Via Benzinga


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.